CY1106074T1 - Πεπτιδια με αντιαγγειογονο δραση - Google Patents

Πεπτιδια με αντιαγγειογονο δραση

Info

Publication number
CY1106074T1
CY1106074T1 CY20061100453T CY061100453T CY1106074T1 CY 1106074 T1 CY1106074 T1 CY 1106074T1 CY 20061100453 T CY20061100453 T CY 20061100453T CY 061100453 T CY061100453 T CY 061100453T CY 1106074 T1 CY1106074 T1 CY 1106074T1
Authority
CY
Cyprus
Prior art keywords
peptides
angiogenic action
angiogenesis
inhibiting angiogenesis
angiogenic
Prior art date
Application number
CY20061100453T
Other languages
English (en)
Inventor
Fortuna Haviv
Jack Henkin
Michael F. Bradley
Douglas M. Kalvin
Andrew J. Schneider
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of CY1106074T1 publication Critical patent/CY1106074T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Πεπτίδια του τύπου (I) Xaal-Xaa2-Xaa3-Xaa4-Xaa5-Xaa6,-Xaa7-Xaa8-Xaa9,-Xaa10-Xaa11 (I), είναι χρήσιμα για την αναστολή της αγγειογένεσης. Επίσης περιγράφονται σκευάσματα που αναστέλλουν την αγγειογένεση και μέθοδοι αναστολής της αγγειογένεσης σε ένα θηλαστικό.
CY20061100453T 1999-11-22 2006-03-31 Πεπτιδια με αντιαγγειογονο δραση CY1106074T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44722599A 1999-11-22 1999-11-22
US70903400A 2000-11-08 2000-11-08
PCT/US2000/032217 WO2001038347A2 (en) 1999-11-22 2000-11-22 Peptides having antiangiogenic activity

Publications (1)

Publication Number Publication Date
CY1106074T1 true CY1106074T1 (el) 2011-06-08

Family

ID=27034912

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061100453T CY1106074T1 (el) 1999-11-22 2006-03-31 Πεπτιδια με αντιαγγειογονο δραση

Country Status (12)

Country Link
EP (1) EP1232183B1 (el)
JP (1) JP2003530313A (el)
AT (1) ATE316102T1 (el)
CA (1) CA2391386A1 (el)
CY (1) CY1106074T1 (el)
DE (1) DE60025648T2 (el)
DK (1) DK1232183T3 (el)
ES (1) ES2256071T3 (el)
HK (1) HK1050012B (el)
MX (1) MXPA02005150A (el)
PT (1) PT1232183E (el)
WO (1) WO2001038347A2 (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020183242A1 (en) * 2001-04-11 2002-12-05 Jack Henkin Peptide antiangiogenic drugs
US20030125260A1 (en) * 2001-10-31 2003-07-03 Fortuna Haviv Tetra-and pentapeptides having antiangiogenic activity
US7122625B2 (en) 2001-10-31 2006-10-17 Abbott Laboratories Hexa-, hepta-, and octapeptides having antiangiogenic activity
US7037897B2 (en) 2001-10-31 2006-05-02 Abbott Laboratories TRI-, TETRA-, and penta-peptides having antiangiogenic activity
US7001984B2 (en) 2001-10-31 2006-02-21 Abbott Laboratories Di-, tri-, and tetra-peptides having antiangiogenic activity
US7067490B2 (en) 2001-10-31 2006-06-27 Abbott Laboratories Hepta-, Octa-and nonapeptides having antiangiogenic activity
US7169888B2 (en) 2001-10-31 2007-01-30 Abbott Laboratories Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
US20030125259A1 (en) 2001-10-31 2003-07-03 Fortuna Haviv Octa- and nonapeptides having antiangiogenic activity
US20030119746A1 (en) * 2001-10-31 2003-06-26 Fortuna Haviv Hepta-and octapeptides having antiangiogenic activity
US20030228365A1 (en) * 2002-06-07 2003-12-11 Fortuna Haviv Pharmaceutical formulation
CA2598833A1 (en) 2005-03-03 2006-09-08 Curt W. Bradshaw Anti-angiogenic compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200397A (en) * 1990-02-22 1993-04-06 W. R. Grace & Co.-Conn. Use of peptide analogs of thrombospondin for the inhibition of angiogenic activity
PT918795E (pt) * 1997-03-17 2005-02-28 Abbott Lab Droga antiangiogenica para tratar cancro artrite e retinopatia

Also Published As

Publication number Publication date
HK1050012B (zh) 2006-09-08
CA2391386A1 (en) 2001-05-31
ES2256071T3 (es) 2006-07-16
WO2001038347A3 (en) 2001-11-29
DE60025648D1 (de) 2006-04-06
DE60025648T2 (de) 2006-09-14
DK1232183T3 (da) 2006-05-29
WO2001038347A2 (en) 2001-05-31
ATE316102T1 (de) 2006-02-15
MXPA02005150A (es) 2003-01-28
EP1232183A2 (en) 2002-08-21
JP2003530313A (ja) 2003-10-14
PT1232183E (pt) 2006-06-30
EP1232183B1 (en) 2006-01-18
HK1050012A1 (en) 2003-06-06

Similar Documents

Publication Publication Date Title
CY1106074T1 (el) Πεπτιδια με αντιαγγειογονο δραση
CY1108001T1 (el) Παραγωγα μερικα αποθειωμενων γλυκοζαμινογλυκανων προικισμενα με αντι-αγγειογονο δραστηριοτητα και χωρις αντιπηκτικη επιδραση
CY1105917T1 (el) Αναλογα ομοιου με γλυκαγονη πεπτιδιου-1
CY1118480T1 (el) Παραγωγα toy uk-2a
CY1106436T1 (el) Φαινυλοφαινανθριδινες με δραση αναστολης pde - ιv
CY1105758T1 (el) Τροποποιημενη απιμιναση αργινινης
CY1113347T1 (el) Πεπτιδια που μειωνουν τα επιπεδα της γλυκοζης στο αιμα
CY1105194T1 (el) Φωσφονικα παραγωγα γλυκοπεπτιδιων
ATE264863T1 (de) 28-epirapaloge
CY1106870T1 (el) Σταθεροποιηση ραπαμυκινης ή παραγωγων ραπαμυκινης
CY1106532T1 (el) Ετερολογος εκφραση των πρωτεϊνων της neisseria
CY1106794T1 (el) Θεραπεια μολυνσης απο μυκητα με πολυενιο ή με αντιμυκητιασικα αναστολεα της συνθασης της βητα γλουκανης σε συνδυασμο με αντισωματα αντι hsp90
CY1108845T1 (el) Συνδυασμοι οι οποιοι περιεχουν εναν αντιδιαρροϊκο παραγοντα και μια εποθιλονη ή ενα παραγωγο εποθιλονης
CY1107485T1 (el) 3-θειομεθυλπυραζoλες ως παρασιτοκτoνα
CY1106359T1 (el) Νεες μεθοδοι και συνθεσεις πepιεχουσες οπιοειδη και ανταγωνιστες αυτων
CY1111648T1 (el) Πολυαρυλκαρβοξαμιδια χρησιμα ως παραγοντες μειωσης λιπιδιων
UY34152A (es) ?oxazolidinonas substituidas y su uso?.
CY1106104T1 (el) Αναστολεις φαρναζυλτρανσφepασης
ITMI992173A0 (it) Derivati isossazalcarbossamidici
TR200103017T2 (tr) Düşük molekül ağırlıklı trombin önleyici içeren formülasyon
CY1108197T1 (el) Βελτιωμενες φαρμακευτικες συνταγοποιησεις αναστολεων πρωτεασης hiv
TR200100455T2 (tr) Nimesulid içeren topikal farmasötik bileşimler
CY1105012T1 (el) Επικαλυψη, διαδικασια παρασκευης και χρηση της σε τεμαχια απο ξυλο
ES2192261T3 (es) Derivados de taxanos que poseen una cadena lateral de c13 sustituida con piridilo y su utilizacion como agentes anti tumores.
ATE315380T1 (de) Epothilon zusammensetzungen